United States Drug Enforcement Administration

WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – In 2023, the U.S. Drug Enforcement Administration marked its 50th anniversary as the only federal agency dedicated to fighting deadly drugs and drug-related violence. This milestone celebrated a half century of dedication to fighting drug trafficking in the United States and around the world, which threatens the public...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

WASHINGTON – The U.S. Drug Enforcement Administration today announced the results of an enforcement operation that spanned from May to September and resulted in significant fentanyl seizures across the United States. As part of the One Pill Can Kill initiative, the DEA and its law enforcement partners seized more than...

WASHINGTON - On Friday, September 9, 2022, the Drug Enforcement Administration dedicated a memorial at DEA Headquarters in Arlington, Virginia to DEA New York Drug Enforcement Task Force Officers who have lost their lives from illness or disease caused by their work at Ground Zero after the terrorist attacks of...

WASHINGTON – On June 14 and 15, DEA Administrator Anne Milgram hosted the first-ever DEA Family Summit on the Overdose Epidemic for families from across the country who have experienced the profound loss of a child due to a drug overdose or poisoning. Deputy Attorney General Lisa O. Monaco delivered...